Attached for your review and comment is WAC 182-530-1080 - Requirements for providers prescribing or dispensing a controlled substance - Prescription monitoring program (PMP).
The agency is conducting this rulemaking regarding provider use of the qualified prescription drug monitoring program, as required by the SUPPORT for Patients and Communities Act (Public Law 115-271).
Comments are due by December 24, 2020.
Return your comments on the proposed rules to:
Melinda Froud, Rules and Publications Program Manager, via e-mail at:
firstname.lastname@example.org or fax to (360) 586-9727.
Direct policy questions to:
Amy Irwin, Pharmacy Services, via e-mail at:
email@example.com with a cc: to firstname.lastname@example.org.
Thank you for your interest in the Health Care Authority’s (HCA) rulemaking process. There will be another opportunity to comment after the official draft is published. All comments are retained in HCA’s permanent rule file and are subject to public review and disclosure, as are the names of those who comment.
**Reminder: You must be signed up for GovDelivery to receive future rulemaking notifications, including the scheduled public hearing, for this rulemaking or any other HCA rulemaking. To sign up, go to HCA’s Rulemaking page and click Sign up for rulemaking notices or go directly to GovDelivery. Once you reach the Subscription Topics, you will see “General and Medicaid rulemaking.” Click the “plus (+) sign to see all the available chapters to select. You can either select “All” or click the specific Chapter(s) you are interested in.